Page last updated: 2024-08-23

fomesafen and meglumine

fomesafen has been researched along with meglumine in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (83.33)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hökfelt, T; Horwell, DC; Hughes, J; Wiesenfeld-Hallin, Z; Xu, XJ2
Hökfelt, T; Hughes, J; Wiesenfeld-Hallin, Z; Xu, XJ1
Elfvin, A; Fournié-Zaluski, MC; Hao, JX; Roques, BP; Wiesenfeld-Hallin, Z; Xu, XJ1
Lucas, GA; Wiesenfeld-Hallin, Z; Xu, XJ1
Broberger, C; Farkas-Szallasi, T; Hökfelt, T; Lundberg, JM; Szallasi, A; Wiesenfeld-Hallin, Z; Xu, XJ1

Other Studies

6 other study(ies) available for fomesafen and meglumine

ArticleYear
PD134308, a selective antagonist of cholecystokinin type B receptor, enhances the analgesic effect of morphine and synergistically interacts with intrathecal galanin to depress spinal nociceptive reflexes.
    Proceedings of the National Academy of Sciences of the United States of America, 1990, Volume: 87, Issue:18

    Topics: Analgesics; Animals; Cholecystokinin; Drug Synergism; Female; Galanin; Indoles; Injections, Spinal; Kinetics; Male; Meglumine; Morphine; Naloxone; Nociceptors; Pain; Peptides; Rats; Rats, Inbred Strains; Receptors, Cholecystokinin; Reflex; Sorbitol; Spinal Cord; Time Factors

1990
Studies on the effect of systemic PD134308 (CAM 958) in spinal reflex and pain models with special reference to interaction with morphine and intrathecal galanin.
    Neuropeptides, 1991, Volume: 19 Suppl

    Topics: Analgesics; Animals; Drug Interactions; Female; Galanin; Indoles; Injections, Intravenous; Injections, Spinal; Male; Meglumine; Morphine; Naloxone; Pain; Peptides; Rats; Rats, Inbred Strains; Receptors, Cholecystokinin; Reflex; Spinal Cord

1991
The CCK-B antagonist CI988 enhances the reflex-depressive effect of morphine in axotomized rats.
    Neuroreport, 1994, Feb-24, Volume: 5, Issue:6

    Topics: Animals; Axons; Depression, Chemical; Drug Synergism; Electromyography; Female; Indoles; Meglumine; Morphine; Nociceptors; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin; Reflex; Sciatic Nerve

1994
CI 988, an antagonist of the cholecystokinin-B receptor, potentiates endogenous opioid-mediated antinociception at spinal level.
    Neuropeptides, 1997, Volume: 31, Issue:3

    Topics: Analgesics; Animals; Decerebrate State; Disulfides; Dose-Response Relationship, Drug; Drug Synergism; Female; Hormone Antagonists; Indoles; Injections, Intravenous; Meglumine; Nociceptors; Opioid Peptides; Phenylalanine; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Reflex; Spinal Cord

1997
On the role of cholecystokinin in the mediation of spinal reflex excitability in intact and axotomized rats.
    Neuropeptides, 1998, Volume: 32, Issue:1

    Topics: Animals; Axotomy; Cholecystokinin; Electric Stimulation; Female; Indoles; Injections, Spinal; Meglumine; Nerve Fibers; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Reflex; Sciatic Nerve

1998
Increased spinal cholecystokinin activity after systemic resiniferatoxin: electrophysiological and in situ hybridization studies.
    Pain, 2000, Volume: 84, Issue:1

    Topics: Animals; Cholecystokinin; Decerebrate State; Diterpenes; Ganglia, Spinal; Hormone Antagonists; Indoles; Injections, Subcutaneous; Male; Meglumine; Morphine; Neurons; Neurotoxins; Pain; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Reflex; RNA, Messenger; Spinal Cord; Time Factors; Transcription, Genetic

2000